ACE and Hypertension: Additionally, 56.3% and 62.5% patients with postinfarction HF used β-receptor blockers and angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, respectively, to treat postinfarction left ventricular remodeling and/or hypertension.